Literature DB >> 16377179

Quality of life in long-term Hodgkin's disease survivors with chronic fatigue.

Marianne J Hjermstad1, Line Oldervoll, Sophie D Fosså, Harald Holte, Anne B Jacobsen, Jon H Loge.   

Abstract

The prevalence of chronic fatigue (CF), elevated fatigue levels >six months, is 2.5-3 times higher in long-term Hodgkin disease survivors (HDSs) than in the general population (GP). This is the first study comparing the quality of life (QoL) of chronic fatigued survivors with that of chronic fatigued subjects in the GP. The fatigue questionnaire (FQ) and the SF-36 were mailed to 591 HDSs successfully treated at the Norwegian Radium Hospital from 1971 to 1997. Patient data were compared with nationally representative GP data, adjusted for age, gender and education. The response rate was 80% (N = 475), median follow-up 195 months (range 53-431), mean age 46 years (range 21-74), and 44% were females. HDSs reported significantly poorer QoL than the GP with lower scores on six of eight SF-36 scales (P < 0.001). The subgroup of HDSs with chronic fatigue however (N = 142/475, 30%) had better QoL on five of eight SF-36 scales than subjects with CF in the GP (N = 224/2141, 11%), particularly mental health and emotional role-functioning (P = 0.005 and <0.0001). No differences were found on the physical SF-36 domains. Overall, HDSs reported lower QoL than the GP, in particular the HDSs with CF. Their QoL was similar to that of GP subjects with CF, but with significantly better mental health status. This suggests that CF in long-term survivors may be associated with more physical than psychological aspects of long-term cancer survivorship.

Entities:  

Mesh:

Year:  2005        PMID: 16377179     DOI: 10.1016/j.ejca.2005.09.028

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  18 in total

Review 1.  Late effects of therapy for Hodgkin's lymphoma.

Authors:  Michael Jacob Adams; Louis S Constine; Steven E Lipshultz
Journal:  Curr Hematol Malig Rep       Date:  2007-07       Impact factor: 3.952

2.  TNF/TNFR1 signaling mediates doxorubicin-induced diaphragm weakness.

Authors:  Laura A A Gilliam; Jennifer S Moylan; Leonardo F Ferreira; Michael B Reid
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-11-19       Impact factor: 5.464

3.  A high level of fatigue among long-term survivors of non-Hodgkin's lymphoma: results from the longitudinal population-based PROFILES registry in the south of the Netherlands.

Authors:  Simone Oerlemans; Floortje Mols; Djamila E Issa; J H F M Pruijt; Wim G Peters; Marnix Lybeert; Wobbe Zijlstra; Jan Willem W Coebergh; Lonneke V van de Poll-Franse
Journal:  Haematologica       Date:  2012-08-28       Impact factor: 9.941

4.  Checkpoint inhibitors and radiation treatment in Hodgkin's lymphoma : New study concepts of the German Hodgkin Study Group.

Authors:  C Baues; R Semrau; U S Gaipl; P J Bröckelmann; J Rosenbrock; A Engert; S Marnitz
Journal:  Strahlenther Onkol       Date:  2016-10-04       Impact factor: 3.621

Review 5.  Hodgkin lymphoma.

Authors:  Joseph M Connors; Wendy Cozen; Christian Steidl; Antonino Carbone; Richard T Hoppe; Hans-Henning Flechtner; Nancy L Bartlett
Journal:  Nat Rev Dis Primers       Date:  2020-07-23       Impact factor: 52.329

Review 6.  A Pound of Cure Requires An Ounce (or More) of Prevention: Survivorship and Complications of Therapy for Hematologic Malignancies.

Authors:  Marlise R Luskin; Rahul Banerjee; Sarah Del Percio; Alison W Loren
Journal:  Curr Hematol Malig Rep       Date:  2015-09       Impact factor: 3.952

7.  Long-term survivorship at a price: late-term, therapy-associated toxicities in the adult hodgkin lymphoma patient.

Authors:  David J Straus
Journal:  Ther Adv Hematol       Date:  2011-04

Review 8.  Long term physical sequelae after adult-onset cancer.

Authors:  Sophie D Fosså; Rena Vassilopoulou-Sellin; Alv A Dahl
Journal:  J Cancer Surviv       Date:  2007-12-04       Impact factor: 4.442

Review 9.  The impact of treatment, socio-demographic and clinical characteristics on health-related quality of life among Hodgkin's and non-Hodgkin's lymphoma survivors: a systematic review.

Authors:  Simone Oerlemans; Floortje Mols; Marten R Nijziel; Marnix Lybeert; Lonneke V van de Poll-Franse
Journal:  Ann Hematol       Date:  2011-06-14       Impact factor: 3.673

10.  Fatigue states after cancer treatment occur both in association with, and independent of, mood disorder: a longitudinal study.

Authors:  David Goldstein; Barbara Bennett; Michael Friedlander; Tracey Davenport; Ian Hickie; Andrew Lloyd
Journal:  BMC Cancer       Date:  2006-10-09       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.